본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Others

[Certest] Zika, Dengue & Chikungunya

Cat-No. VS-ZDC112



certest는 분자진단 및 면역진단 분야에서 감염성 질환 진단 솔루션을 전문적으로 개발·제조하는 스페인 생명과학 기업입니다. 








제품 설명


Zika, Dengue & Chikungunya

  



제품 번호


VS-ZDC112

 



제품 특징


Description

VIASURE Zika, Dengue & Chikungunya Real Time PCR Detection Kit is designed for specific detection and differentiation of Zika, Dengue and/or Chikungunya viruses in clinical samples from patients with signs and symptoms of Zika, Dengue and/or Chikungunya viruses infection.

This test is intended for use as an aid in the diagnosis of the Zika, Dengue and/or Chikungunya viruses in combination with clinical and epidemiological risk factors.

RNA is extracted from specimens, amplified using RT-PCR and detected using fluorescent reporter dye probes specific for Zika and Dengue and Chikungunya viruses.


Specifications

Method
Real Time PCR

Specimen Type
Blood / Serum / Plasma / Urine / ...and others

Storage up to
(From production) 2 years.

Storage temperature
(Also transport) Room temperature


Information

Zika (ZIKV), Dengue (DENV) and Chikungunya (CHIKV) are arthropod-borne viruses (arboviruses) that share mosquitos of the Aedes genus as common vector, specifically A. aegypti and A. albopictus. Environmental changes, urbanization and the globalization of travel have enhanced the spread of ZIKV, DENV and CHIKV resulting in epidemics and the co-circulation in overlapping geographic areas as well as the possibility of viral coinfection within a single host. Currently the major endemic regions include Africa, Southeast Asia, the Pacific Islands and the Americas.

img_web_VIASURE_Multiplex_det-copia

Besides, these arboviruses cause similar clinical presentations, especially in the initial stages of infection (fever, headache, skin rash, muscle and join pain, and gastrointestinal symptoms). In fact, due to neither virus possesses any specific distinguishing clinical features and the outcomes and management strategies for these three viruses are vastly different, an early and accurate diagnosis is imperative.

Therefore, ZIKV, DENV and CHIKV must be initially included in the differential diagnosis for a patient with suspicious clinical symptoms who is living in or returning from travel to an endemic area. Laboratory diagnostic tests are based on the detection of the virus, viral components (antigens or nucleic acid), or the host immunologic response to the virus. However, due to the cross-reactivity of the antibodies of these arboviruses limits the use of serology, Real Time RT-PCR is a detection method commonly used during the acute phase of the infection. In order to do that, clinical specimens that can be tested including blood, serum, plasma, urine and others.





certest의 모든 제품을 만나보세요!



certest - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"